Skip to content

CorMedix CRMD Gross margin

Gross margin at other companies

Pfizer logo
PfizerPFE
73.5%+1.2pp
Merck & Co. logo
Merck & Co.MRK
73.9%-2.5pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
48.7%+0.9pp
ITG
Integer HoldingsITGR
26.4%-0.6pp
IAR
Integra LifeSciencesIART
51.9%-1.6pp
MiMedx Group logo
MiMedx GroupMDXG
81%-0.9pp

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Calculated from CorMedix’s reported figures.

Based on trailing twelve months.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's gross margin?
CorMedix (CRMD) reported gross margin of 91.9% in Q1 2026.
How has CorMedix's gross margin changed year-over-year?
CorMedix's gross margin decreased by 3.7% year-over-year, from 95.4% to 91.9%.
What is the long-term trend for CorMedix's gross margin?
Over 4 years (2020 to 2025), CorMedix's gross margin has grown at a 57.7% compound annual growth rate (CAGR), from 15% to 92.9%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.